TheraRadar

Pharma Intelligence, Simplified

← All Targets

Androgen Receptor

7 drugs
Oncology
Market Leader
XTANDI
ASTELLAS
3
approved indications
7
Approved Drugs
7
Companies
7
Indications
1
Therapeutic Areas
Unlock Full Target Intelligence PRO
Competitive landscape by company (7 companies)
All 7 approved drugs
Therapeutic area breakdown
Full indication list (7 indications)
Patent cliff analysis
Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo

Drugs by Company

ASTELLAS 1 drug
Johnson & Johnson 1 drug
ZYDUS 1 drug

By Therapeutic Area

Oncology 4 drugs
Other 3 drugs